AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Onex, you need to be comfortable with a diversified, transaction‑driven business where earnings can swing from quarter to quarter, yet capital returns stay a central focus. The latest Q2 2026 results showed softer revenue and net income versus last year, which reinforces one of the near‑term risks: lumpier performance from investment realizations and asset management fees. At the same time, the board’s decision to keep the C$0.10 dividend and continue buybacks suggests management still sees its balance sheet and liquidity as supportive of ongoing shareholder returns. For most short‑term catalysts, such as further buyback execution or portfolio exits, this earnings miss looks more like a reminder of volatility than a thesis‑changer, but it does sharpen attention on execution risk and governance, including CEO pay versus recent profit trends.
However, there is a governance issue here that investors should be aware of. Onex's shares are on the way up, but they could be overextended by 23%. Uncover the fair value now.Explore 2 other fair value estimates on Onex - why the stock might be worth as much as 31% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com